Carregant...
Immune checkpoint inhibitor—related dermatologic adverse events
Immune checkpoint inhibitors have emerged as a pillar in the management of advanced malignancies. However, nonspecific immune activation may lead to immune-related adverse events, wherein the skin and its appendages are the most frequent targets. Cutaneous immune-related adverse events include a div...
Guardat en:
| Publicat a: | J Am Acad Dermatol |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7572894/ https://ncbi.nlm.nih.gov/pubmed/32454097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2020.03.132 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|